
Sign up to save your podcasts
Or


By Society of Critical Care Medicine (SCCM)
3.9
9494 ratings
The podcast currently has 587 episodes available.
The most played episodes among Podcast App listeners.

Central venous access remains foundational to the delivery of critical care, yet the techniques used for central line insertion have evolved minimally since the introduction of the Seldinger method more than 70 years ago. This relative stagnation persists despite increasing patient complexity and heightened expectations for procedural safety, efficiency, and reliability. This episode of the Society of Critical Care Medicine (SCCM) Podcast examines how procedural variability and fragmented workflows continue to contribute to risk during central venous catheter insertion in critically ill patients. It also considers the growing need to reassess long-standing approaches that may no longer align with the demands of contemporary ICU practice. Host Kyle B. Enfield, MD, speaks with Adnan Javed, MD, about emerging insertion techniques and integrated technologies designed to simplify procedural steps, reduce variability, and support more consistent performance at the bedside. Through a focused exploration of innovation in procedural design, this discussion highlights how streamlined, integrated approaches may enhance clinician performance, improve safety, and advance the standard of care in high-acuity environments. This episode provides a critical perspective on the future of central venous access and the role of innovation in transforming a commonly performed, yet high-stakes, procedure. This episode is sponsored by BD. Learning Objectives Describe how procedural complexity and workflow variability contribute to risk during central venous catheter insertion in critically ill patients Understand the potential of emerging insertion techniques and integrated, simplified approaches to improve procedural safety, consistency, and clinician performance Resource referenced in this episode: Pronovost P, Needham D, Berenholtz S, et al. An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. doi:10.1056/NEJMoa061115

Sepsis management has traditionally focused on timely antibiotic treatment, hemodynamic support, and source control, but emerging evidence suggests that outcomes may be shaped long before patients reach the ICU. In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FCCM, speaks with Sayed Abdulmotaleb Almoosawy, MBChB (Hons), about his article “The Association Between Socioeconomic Position and Mortality in Patients With Sepsis and Septic Shock—A Systematic Review and Meta-Analysis,” published in the April 2026 issue of Critical Care Medicine. Drawing on 13 observational studies that encompassed nearly 4 million patients, the analysis evaluates how factors such as insurance status, income, education, and neighborhood deprivation relate to short-term mortality outcomes. The findings reveal a consistent association between lower socioeconomic position and increased mortality, with lack of private insurance demonstrating the strongest signal—likely reflecting barriers to timely access to care and delayed presentation. This episode challenges clinicians and researchers alike to recognize the link between socioeconomic disadvantages and worse sepsis outcomes, highlighting the need to collect equity-relevant data and reduce gaps in care to improve survival for critically ill patients. Resources referenced in this episode: Almoosawy SA, Fernando SM, Rochwerg B, et al. The association between socioeconomic position and mortality in patients with sepsis and septic shock—a systematic review and meta-analysis. Crit Care Med. 2026;54(4):692-700. Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026;54(4):725-812.

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FNCS, FCCM, is joined by Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, and Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, to discuss the 2026 guidelines for neuromuscular blockade in adult patients with acute respiratory distress syndrome. The guidelines, “Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome,” were published in the March issue of Critical Care Medicine. Drs. Sarwal and Erstad discuss how the evidence in two key trials, ACURASYS and PETAL-ROSE, has helped shape the recommendations provided in the SCCM guidelines. Despite how influential these trials were in shaping the recommendations, only conditional recommendations were made due to low or very low quality of evidence. The lack of evidence proved to be a driving factor in including a call to action in the guidelines. Future research priorities largely revolve around precision medicine and finding more patient-specific interventions to improve patient outcomes. Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, is a professor of neurology and the division chair of neurocritical care at Virginia Commonwealth University (VCU) School of Medicine in Richmond, Virginia, USA. She is also an associate editor of Critical Care Medicine, secretary of the American Society of Neuroimaging, and director of VCU-Wake Forest neuro-ultrasound courses. Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, is a tenured professor and interim dean at the University of Arizona R. Ken Coit College of Pharmacy in Tucson, Arizona, USA. He is also a center investigator for the Center for Health Outcomes, a member of the BIO5 Institute and Comprehensive Center for Pain & Addiction and Pharmacoeconomics Research Center, and a codirector for the Arizona Clinical and Translational Research Graduate Certificate Program. Resources referenced in this podcast: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Kyle B. Enfield, MD, FCCM, welcomes Vincenzo Russotto, MD, of the University of Turin in Turin, Italy to discuss Dr. Russotto’s article, “Induction Agents for Tracheal Intubation in Critically Ill Patients,” published in the January 2025 issue of Critical Care Medicine. Drs. Enfield and Russotto explore the decision of which induction drugs to use for patients undergoing tracheal intubation. They discuss research challenges such as the ethics of which drugs can be tested on patients and the emergent nature of many tracheal intubations. Dr. Russotto discusses the advantages and disadvantages of ketamine as an induction agent and describes current clinical thinking on etomidate and propofol. His study made no definitive conclusions but found evidence that ketamine may have a safer profile and etomidate and propofol may be associated with negative effects. Dr. Russotto emphasizes the need to individualize patient treatment and shares examples of induction agent combinations. He encourages clinicians to consider hemodynamic optimization along with the use of intubation agents. Listeners will gain insights to inform patient care. Resources referenced in this episode: Induction Agents for Tracheal Intubation in Critically Ill Patients (Kotani Y, et al. Crit Care Med. 2025;53:e173-e181).

What form of renal replacement therapy should clinicians use for patients in the intensive care unit (ICU)? New research has connected the renal replacement therapy choice with mortality end points and renal replacement therapy dependency in patients with acute kidney injury. In this podcast episode, experts discuss their research in this area. Ron Wald, MDCM, MHP, professor of medicine at the University of Toronto, discusses his article, “Initiation of Continuous Renal Replacement Therapy Versus Intermittent Hemodialysis in Critically Ill Patients With Severe Acute Kidney Injury: A Secondary Analysis of STARRT-AKI Trial,” published in the November 2023 issue of Intensive Care Medicine. Jay Koyner, MD, professor of medicine and director of the nephrology intensive care unit at the University of Chicago, discuss his article, “Initial Renal Replacement Therapy (RRT) Modality Associates With 90-Day Postdischarge RRT Dependence in Critically Ill AKI Survivors,” published in the August 2024 issue of Journal of Critical Care. This podcast is sponsored by Vantive U.S. Healthcare. Vantive supports true patient-focused treatments with industry-leading CRRT technology and is a partner dedicated to optimizing your clinical success in treating patients with acute kidney injury. Our commitment to you starts with education and provides complete support every step of the way. Visit us at vantive.com.
The podcast currently has 587 episodes available.

1,868 Listeners

317 Listeners

546 Listeners

500 Listeners

1,304 Listeners

256 Listeners

889 Listeners

1,472 Listeners

2,447 Listeners

3,364 Listeners

271 Listeners

1,149 Listeners

370 Listeners

257 Listeners

269 Listeners